FI954646A - (S)-alfa-fenyl-2-pyridinetanaminbenzoat och dess användning som medicin - Google Patents

(S)-alfa-fenyl-2-pyridinetanaminbenzoat och dess användning som medicin Download PDF

Info

Publication number
FI954646A
FI954646A FI954646A FI954646A FI954646A FI 954646 A FI954646 A FI 954646A FI 954646 A FI954646 A FI 954646A FI 954646 A FI954646 A FI 954646A FI 954646 A FI954646 A FI 954646A
Authority
FI
Finland
Prior art keywords
alpha
phenyl
medicine
pyridineethanamine
benzoate
Prior art date
Application number
FI954646A
Other languages
English (en)
Finnish (fi)
Other versions
FI109019B (sv
FI954646A0 (sv
Inventor
Robert John Murray
Donald Mathisen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB1993/000689 external-priority patent/WO1993020052A1/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI954646A0 publication Critical patent/FI954646A0/sv
Publication of FI954646A publication Critical patent/FI954646A/sv
Application granted granted Critical
Publication of FI109019B publication Critical patent/FI109019B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI954646A 1993-04-01 1995-09-29 Förfarande för framställning av (S)-alfa-fenyl-2-pyridinetanaminbenzoat FI109019B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/GB1993/000689 WO1993020052A1 (en) 1992-04-03 1993-04-01 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
GB9300689 1993-04-01
GB9400716 1994-04-05
PCT/GB1994/000716 WO1994022832A1 (en) 1993-04-01 1994-04-05 (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament

Publications (3)

Publication Number Publication Date
FI954646A0 FI954646A0 (sv) 1995-09-29
FI954646A true FI954646A (sv) 1995-11-29
FI109019B FI109019B (sv) 2002-05-15

Family

ID=10728731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954646A FI109019B (sv) 1993-04-01 1995-09-29 Förfarande för framställning av (S)-alfa-fenyl-2-pyridinetanaminbenzoat

Country Status (13)

Country Link
EP (1) EP0691958B1 (sv)
JP (1) JP3023988B2 (sv)
AT (1) ATE156814T1 (sv)
AU (1) AU682350B2 (sv)
CA (1) CA2159480C (sv)
DE (1) DE69404975T2 (sv)
DK (1) DK0691958T3 (sv)
ES (1) ES2105679T3 (sv)
FI (1) FI109019B (sv)
GR (1) GR3025082T3 (sv)
NO (1) NO304648B1 (sv)
WO (1) WO1994022832A1 (sv)
ZA (1) ZA942140B (sv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
EP0356035B1 (en) * 1988-08-12 1996-03-13 Astra Aktiebolag Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
CZ288519B6 (cs) * 1992-04-03 2001-07-11 Astra Ab (S)-alfa-Fenyl-2-pyridinethanamin, způsob jeho přípravy, farmaceutická kompozice tento enantiomer obsahující, tento enantiomer pro použití jako léčivo a použití tohoto enantiomeru pro výrobu léčiva

Also Published As

Publication number Publication date
NO953847D0 (no) 1995-09-28
DE69404975D1 (de) 1997-09-18
CA2159480C (en) 2005-01-25
NO953847L (no) 1995-11-22
GR3025082T3 (en) 1998-01-30
JP3023988B2 (ja) 2000-03-21
AU6433794A (en) 1994-10-24
EP0691958A1 (en) 1996-01-17
ATE156814T1 (de) 1997-08-15
FI109019B (sv) 2002-05-15
AU682350B2 (en) 1997-10-02
ZA942140B (en) 1994-10-03
FI954646A0 (sv) 1995-09-29
DK0691958T3 (da) 1997-12-08
NO304648B1 (no) 1999-01-25
DE69404975T2 (de) 1997-12-18
JPH08508475A (ja) 1996-09-10
ES2105679T3 (es) 1997-10-16
WO1994022832A1 (en) 1994-10-13
EP0691958B1 (en) 1997-08-13
CA2159480A1 (en) 1994-10-13

Similar Documents

Publication Publication Date Title
DE69434376D1 (de) Videotrainingsverfahren und display
EP0624635A3 (en) Pressure sensitive adhesives for medical use and medical band formed therefrom.
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
FI954645A0 (sv) (S)-alfa-fenyl-2-pyridinetanamin-(S)-malat och dess användning som medicin
FI973185A0 (sv) Användning av melatonin för behandling av patienter som lider av läkemedelsberoende
FI954646A (sv) (S)-alfa-fenyl-2-pyridinetanaminbenzoat och dess användning som medicin
ITMI930341A1 (it) Impiego terapeutico del pirrolidon carbossilato di piridossina
FI964113A (sv) Medicinsk sammansättning för behandling av tardiv dyskinesi och användning av densamma
IT1273202B (it) Procedimento e dispositivo per la microfinitura di ruote dentate
SE8900564D0 (sv) Novel medicinal use
FR2702151B1 (fr) Application d'anticonvulsivants dans le traitement du neuro-sida.
AU1192495A (en) Use of selegiline and its derivatives for the treatment of psoriasis
ID15808A (id) Penggunaan protease dibidang kedokteran
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
LV10385A (lv) Hinonu lietosana veza un AIDS arstesana
UA18225A (uk) Спосіб лікуваhhя раh
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin
ITFI930069A1 (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.

Legal Events

Date Code Title Description
MA Patent expired